Baron & Budd Files Suit Against Pharmaceutical Distributors for Role in Creating Opioid Crisis in Baton Rouge
Parish of East Baton Rouge takes bold step to hold pharmaceutical distributors and drug wholesalers...READ MORE
Xarelto lawsuits have been filed across the country by patients who have suffered severe health complications and the families of people who have passed away after uncontrolled bleeding events. If you are considering this type of legal action, here is a quick background on how the litigation is progressing.
Plaintiffs in Xarelto lawsuits are alleging that the drug, which is manufactured by Johnson & Johnson subsidiary Janssen Pharmaceuticals, has caused severe health problems in people who have taken the medication. These include strokes, bleeding of the brain and stomach, and even death. Plaintiffs also allege that Janssen, Johnson & Johnson and Bayer Healthcare (the marketer of the drug) failed to warn doctors and patients of the potential dangers of Xarelto.
Even though the first complaints were not filed until 2014, as of August 2015 there were approximately 2,000 Xarelto lawsuits across the country – and that number was expected to rise substantially in the coming months. The U.S. Judicial Panel for Multidistrict Litigation consolidated all federal Xarelto injury cases into the U.S. District Court of the Eastern District of Louisiana. Judge Eldon Fallon is overseeing the litigation.
A small group of these lawsuits, known as bellwether cases, will likely be heard sometime in 2016. These cases will paint a good picture of how future juries will likely respond to the testimony and evidence provided. The outcomes will not be binding in relation to those future cases, but they will probably determine what types of settlement offers may be forthcoming from the drug maker.
Similar claims were made against Boehringer Ingleheim, the maker of Pradaxa, another of the new generation of blood thinners. The company paid nearly $700 million to settle approximately 4,000 claims.